Skip to main content
OpenTrials
Completed

NCT Number: NCT02900339

Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects

Magnetic resonance imaging (MRI) is a noninvasive and non-ionizing (no use of X-rays) imaging modality. Today it is considered an anatomical and functional exploration reference technique. Since its inception around 1985, this technology is constantly evolving.

Many advances in MRI require constant adaptations of radiological practices. The morphological image is now associated with functional and parametric information (infusion, diffusion spectroscopy, etc ...). In parallel, work combining acquisition and post-processing of data also open new applications (tractography, functional MRI, etc ....). Thus, more and more procedures are necessary to "integrate" these techniques for the diagnosis and adapt to new demands of clinicians.

The type of sequence and its associated parameters allow to directly influence the contrast of images, to characterize tissue compared to another and, ultimately, to highlight morphological or functional abnormality. Image quality can be optimized on each MRI, depending on the time available for the acquisition on the one hand, and on the desired resolution and contrast, on the other hand. For each sequence, it is therefore necessary to find a compromise that will optimize the diagnostic quality of the examination.

This optimization requires a phase focusing on healthy volunteers. It is therefore important that researchers and physicists could design on healthy volunteers, the best settings of all parameters for an image or spectrum. Indeed, it is always necessary to properly optimize every parameter choices before beginning a study of a cohort of patients.

In this context, the main objective of this study is to optimize sequences and imaging protocols to evaluate and validate the choice of parameters in healthy volunteers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Radiology Department CHU de Rennes

Rennes, 35033, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men or women aged over 18 years
  • Written informed consent given

Exclusion criteria

  • contraindication to MRI :
  • Claustrophobia
  • morphotype not allowing access to MRI
  • Wear a metallic implant, such as:
  • Pacemaker (pacemaker)
  • Ferromagnetic surgical clips
  • Intra orbital metallic foreign bodies or encephalic
  • Pregnancy
  • Breastfeeding
  • Adults under guardianship, trusteeship or safeguard justice
  • No social Insurance

Treatment and study plan

Magnetic Resonance Imaging

Device

MRI of the Neurinfo platform is an MRI 3 Tesla Magnetom Verio model, Siemens (Siemens Healthcare, Erlangen, Germany). This imager is marked for European Conformity (CE), ensuring compliance with European Union safety standards.

Other names: Magnetom

Primary outcomes

  1. Quantitative assessment of acquired sequences

    Time frame: One day after data acquisitions

    Quality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions.

    This evaluation will be based on quantitative criteria extracted from computer analysis of the data : signal to noise ratio, contrast-to-noise, blur level, information sharing, collocation of areas set evidenced by the different techniques, etc...

Secondary outcomes

  1. Qualitative assessment of acquired sequences

    Time frame: One day after data acquisitions

    Quality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions.

    This evaluation will be based on statistical comparison of visual qualitative criteria by experts radiologists

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Official study title

MRI Sequences Optimization in Healthy Subjects

Acronym: OSS-IRM

Important dates

Study start
2013
Primary completion
2021
Study completion
2021
First posted
Sep 14, 2016
Registry last updated
Dec 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.